Moreover, PD-L1 positivity in cancer cells was not significantly associated with cancer-specific survival (CSS) and OS in non-ccRCC; however, a trend for improved survival was seen for PD-L1-positive tumors. This evidence concerns the gene CD274 and nonpapillary renal cell carcinoma.